Clinical research in Poland
Poland is located in Central Europe at the Baltic Sea, having among its neighbors countries like Germany, Russia, Ukraine, and the Czech Republic. Travelers are welcome to explore it's rich and varied history, vibrant and diverse culture: medieval old towns and Jewish quarters stand next to modern steel-and-glass business centers and beautiful parks.
Clinical trials in Poland
Poland remains to be one of the largest clinical trial markets in CEE, having a share close to 20% in terms of the number of clinical trials held. Health care in Poland is free and is delivered through a publicly funded health care system, but the private sector is steadily growing as well. The clinical trials market in Poland is well organized, mature, and presents a valuable and acknowledged potential.
An EU member since 2004, Poland has its medical and pharmaceutical legislation harmonized with the EU. The typical timeline for receiving authorization from the regulatory authorities to conduct medicinal or device trials is 60 days.
Poland has a population of 38 million. The patients are motivated to participate in the trials, as this often provides access to better and queue-free treatment. Therapy-naive subjects may be available.
The Investigators and Site staff are highly qualified and interested in participation, as this creates opportunities for hands-on testing of new treatments, scientific knowledge exchange, publications co-authoring, and financial benefits. The Investigators are familiar with ICH-GCP, modern treatment standards and experienced in clinical trials, capable of delivering high-quality data.
There is a considerable number of specialized medical centers clustered around the major population centers, mostly being academic medical centers and major specialized hospitals. The total number of potential clinical trial sites exceeds 1,400. The sites are well equipped and follow a modern standard of diagnostics and treatment.
Cardiovascular diseases, Neoplasms, Oncology, and Respiratory diseases are prevalent therapeutic areas with the highest number of clinical trials.
Key local authority: Ministry of Health of Poland